They also confirmed that knockdown of DUXAP10 could result in inhibited proliferation, migration, invasion and enhanced apoptosis in renal cell carcinoma through interacting with RNA-binding proteins, EZH2 and LSD1. This evidence concerns the gene DUXAP10 and hereditary clear cell renal cell carcinoma.